Posted Dec. 9, 2011 at 10:11 a.m.

Premium Lock Drug trial failure sends Furiex Pharmaceuticals stock down 6%

Published: 2011-12-09 10:11:03
Updated: 2011-12-09 10:11:03

Print this blog post
Furiex Furiex

Shares in Morrisville-based Furiex Pharmaceuticals fell 6 percent in trading Friday after the company disclosed failure of a drug candidate in a Phase II clinical trial....

Read More
Read More

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners


Frank Vinluan
Life science
Vivek Wadhwa
Dr. Mike Walden
Tech economy